The ‘technical’ name is AZD1222 (ChAdOx1) and it has been developed on non replicating viral vector technology. It is the collaboration between the University of Oxford and AstraZeneca.
The vaccine consists of 2 shots 85 days apart in the muscle of the upper arm. It is reported to be effective at least at 63% in clinical trials with shots 28 days apart. It has been reported that with 85 days, effectiveness should rise at 80+%.
Latest results (22 March 2021) are extremely good (BBC article here)
Storage: between 1 and 8 C.
Price (approx) 25 / 37 USD per dose
It is reported to have side effects like pain the injected spot, and sometimes tiredness, headache, muscle pain, chills, fever and nausea
It is reported to be working against the latest variants (UK and Brazil) but less with the South African.
Countries that have approved and that are using this vaccine against covid19: basically everyone, except USA so far. It is used by COVAX